Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosis

MLA

Valentina Taglietti, et al. “Duchenne Muscular Dystrophy Trajectory in R-DMDdel52 Preclinical Rat Model Identifies COMP as Biomarker of Fibrosis.” Acta Neuropathologica Communications, vol. 10, no. 1, Apr. 2022, pp. 1–19. EBSCOhost, https://doi.org/10.1186/s40478-022-01355-2.

APA

Valentina Taglietti, Kaouthar Kefi, Iwona Bronisz-Budzyńska, Busra Mirciloglu, Mathilde Rodrigues, Nastasia Cardone, Fanny Coulpier, Baptiste Periou, Christel Gentil, Melissa Goddard, François-Jérôme Authier, France Pietri-Rouxel, Edoardo Malfatti, Peggy Lafuste, Laurent Tiret, & Frederic Relaix. (2022). Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosis. Acta Neuropathologica Communications, 10(1), 1–19. https://doi.org/10.1186/s40478-022-01355-2

Chicago

Valentina Taglietti, Kaouthar Kefi, Iwona Bronisz-Budzyńska, Busra Mirciloglu, Mathilde Rodrigues, Nastasia Cardone, Fanny Coulpier, et al. 2022. “Duchenne Muscular Dystrophy Trajectory in R-DMDdel52 Preclinical Rat Model Identifies COMP as Biomarker of Fibrosis.” Acta Neuropathologica Communications 10 (1): 1–19. doi:10.1186/s40478-022-01355-2.